• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,704.13 633.29
( 0.83%)
Global Indices
Nasdaq
47,030.54 63.12
(0.13%)
Dow Jones
6,739.22 18.84
(0.28%)
Hang Seng
55,100.12 1,399.73
(2.61%)
Nikkei 225
10,289.25 -114.35
(-1.10%)
Forex
USD-INR
92.33 0.01
(0.01%)
EUR-INR
105.92 0.52
(0.49%)
GBP-INR
122.63 0.58
(0.47%)
JPY-INR
0.58 0.00
(0.31%)

EQUITY - MARKET SCREENER

Intense Technologies Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
532326
INE781A01025
53.8095024
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INTENTECH
259.71
208.6
EPS(TTM)
Face Value()
Div & Yield %
0.34
2
1.12
 

Kilitch Drugs (India) consolidated net profit declines 4.99% in the September 2025 quarter
Nov 15,2025
Net profit of Kilitch Drugs (India) declined 4.99% to Rs 8.19 crore in the quarter ended September 2025 as against Rs 8.62 crore during the previous quarter ended September 2024. Sales rose 3.05% to Rs 48.92 crore in the quarter ended September 2025 as against Rs 47.47 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales48.9247.47 3
OPM %10.3012.85 -
PBDT10.2610.95 -6
PBT9.4010.35 -9
NP8.198.62 -5